analyst
NC
NASDAQ · NCEL
Kadimastem Ltd
Healthcare · Biotechnology
$3.60
Down-$0.25 (-6.94%)
Updated Aug 14, 2026, 6:32 PM
SID Score
4.1/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.5M
- P/E ratio
- -1.69
- Dividend yield
- 0.00%
- 52-week range
- $1.83 – $5.12
- Volume
- 7.81K
- Avg. volume
- 200.47K
Price performance
NCEL price history
1M range · 21 trading sessions · Daily adjusted prices
NCEL closed at $3.60 after 21 trading sessions, down 7.93% for the selected period.
- Last close
- $3.60
- Period change
- -7.93%
- Period low
- $3.19
- Period high
- $4.09
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 13, 2026 | $3.33 | $3.60 | $3.225 | $3.60 | 7.81K |
| Aug 12, 2026 | $3.13 | $3.35 | $3.13 | $3.33 | 2.67K |
| Aug 11, 2026 | $3.235 | $3.25 | $3.09 | $3.19 | 17.8K |
| Aug 10, 2026 | $3.20 | $3.32 | $3.16 | $3.25 | 14.51K |
| Aug 7, 2026 | $3.28 | $3.335 | $3.235 | $3.31 | 4.46K |
| Aug 6, 2026 | $3.36 | $3.60 | $3.27 | $3.34 | 20.8K |
| Aug 5, 2026 | $3.54 | $3.75 | $3.49 | $3.56 | 5.97K |
| Aug 4, 2026 | $3.585 | $3.74 | $3.3601 | $3.45 | 5.71K |
| Aug 3, 2026 | $3.61 | $3.725 | $3.42 | $3.42 | 16.18K |
| Jul 31, 2026 | $3.44 | $3.68 | $3.36 | $3.49 | 10.14K |
| Jul 30, 2026 | $3.48 | $3.63 | $3.15 | $3.3614 | 9.73K |
| Jul 29, 2026 | $3.54 | $3.7463 | $3.50 | $3.52 | 9.56K |
| Jul 28, 2026 | $3.59 | $3.6499 | $3.48 | $3.48 | 9.28K |
| Jul 27, 2026 | $3.70 | $3.765 | $3.41 | $3.60 | 7.29K |
| Jul 24, 2026 | $3.69 | $3.755 | $3.65 | $3.755 | 6.08K |
| Jul 23, 2026 | $3.70 | $3.80 | $3.66 | $3.80 | 13.05K |
| Jul 22, 2026 | $3.76 | $3.7999 | $3.65 | $3.65 | 5.66K |
| Jul 21, 2026 | $3.84 | $3.9518 | $3.75 | $3.81 | 12.35K |
| Jul 20, 2026 | $4.16 | $4.16 | $3.65 | $3.97 | 15.15K |
| Jul 17, 2026 | $3.84 | $4.155 | $3.70 | $4.09 | 14.22K |
| Jul 16, 2026 | $3.85 | $3.995 | $3.66 | $3.91 | 19.85K |
Latest NCEL news
The latest Smart Investors Daily articles mentioning NCEL.
Stock researchResearch & News · News
Loading stock research…

